GSK is the latest to turn its back on prominent industry lobbying group Biotechnology Innovation Organization (BIO), ...

GSK CEO Emma Walmsley said the sector would need to wait to see who is appointed in key roles in the Trump administration to ...

The US group's division has reported a pre-tax profit of $39.5m (£30.6m) for the 12 months to 31 January, 2024, according to ...

Profit at the UK arm of software giant Workday almost doubled during its latest financial year, it has been revealed.

On Tuesday night, millions of Americans watched as former president Donald J. Trump gathered up enough electoral votes needed ...

By enhancing DEI strategies, UK firms can set themselves apart, fostering inclusivity that drives growth – Reshma Sheikh explains As major US firms like Harley Davidson, Brown-Forman and Molson Coors ...

This week saw two major life sciences investments in London, as GSK unveiled plans to move its headquarters to a central location in the city, while an ambitious plan to develop a new biosciences ...

SALES: The London-listed group's third-quarter sales are forecast at ... coming months and materially harm Chinese sales for the next few years, taking cues from GSK's 2013 Chinese bribery scandal, ...

Not too long ago, pharmaceutical giant Astrazeneca reached a £200bn valuation—one of only a few London-listed FTSE 100 ...

This looks like an appealing, diversified option for dividends. The post One high-yield ASX dividend ETF to buy to generate ...

While London South East do their best to maintain the high quality of the information displayed on this site, we cannot ...